CHMP Recommends Advertising and marketing of Biologic for Atopic Dermatitis
The Committee for Medicinal Merchandise for Human Use (CHMP) of the European Medicines Company (EMA) has beneficial advertising authorization of lebrikizumab...
The Committee for Medicinal Merchandise for Human Use (CHMP) of the European Medicines Company (EMA) has beneficial advertising authorization of lebrikizumab...